2[2]Faukh D.Heel RC.Ganciclovic a review of its antiviral activity,pharmacokinetic properties and therapeutic eflicacy in cy-tomegslovirus ifections[J].Drugs,1990,39:597-638.
3[3]Mc gavin JK,Goa KL.Ganciclovir:an update of its use in the pre-vention of cytomegalovirus infection and disease in transplant reeip-ients[J].Drugs,2001,61:1153-1183.
二级参考文献4
1Helgason S, Petursson G, Gudmundsson S, et al. Prevalence of postherpetic neuralgia after a first episode of herpes zoster: prospective study with long term follow up. BMJ,2000,321 (7264): 794-796.
2Baron R. Peripheral neuropathic pain: from mechanisms to symptoms.Clin J Pain, 2000 , 16(2 Suppl): S12-20.
3Bonezzi C, Demartini L. Treatment options in postherpetic neuralgia. Acta Neurol Scand Suppl, 1999,173: 25-35.
4Chiarello SE. Tumescent infiltration of corticosteroids, lidocaine, and epinephrine into dermatomes of acute herpetic pain or postherpetic neuralgia. Arch Dermatol, 1998 , 134(3) :279-281.
